Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
Federica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Cisplatin Mouse Models: Treatment, Toxicity and Translatability
Martina Perše
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1406-1406
Open Access | Times Cited: 90
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Iris Lodewijk, Sandra P. Nunes, Rui Henrique, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 60
The paradigm of drug resistance in cancer: an epigenetic perspective
Swagata Adhikari, Apoorva Bhattacharya, Santanu Adhikary, et al.
Bioscience Reports (2022) Vol. 42, Iss. 4
Open Access | Times Cited: 46
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment
Elaheh Dalir Abdolahinia, Xiaozhe Han
Cancers (2023) Vol. 15, Iss. 17, pp. 4266-4266
Open Access | Times Cited: 14
Effect of valproic acid on histone deacetylase expression in oral cancer (Review)
Ahmed S. Al-Khafaji, Lydia M. Wang, Haidar H Alabdei, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 6
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
Camilla Palumbo, Monica Benvenuto, Chiara Focaccetti, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Current update on pharmacological strategies of penile cancer
Sameer Deshmukh, Kaustubh S. Chaudhari, Arnab Basu, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Repurposing Antiepileptic Drugs for Cancer: A Promising Therapeutic Strategy
Noor Tarawneh, S. A. Hussein, Shtaywy Abdalla
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2673-2673
Open Access
Epithelial–mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC
Julia Lima de Oliveira, Thaís Moré Milan, Rayana Longo Bighetti‐Trevisan, et al.
Oral Diseases (2022) Vol. 29, Iss. 5, pp. 1991-2005
Closed Access | Times Cited: 15
Models of head and neck squamous cell carcinoma using bioengineering approaches
А. П. Бонарцев, Bo Lei, Margarita S. Kholina, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 175, pp. 103724-103724
Closed Access | Times Cited: 13
Cisplatin-Based Combination Therapy for Enhanced Cancer Treatment
Qi Li, Siwei Chen, Xiao Wang, et al.
Current Drug Targets (2024) Vol. 25, Iss. 7, pp. 473-491
Closed Access | Times Cited: 2
Magnesium in Combinatorial With Valproic Acid Suppressed the Proliferation and Migration of Human Bladder Cancer Cells
Tianye Li, Yang Yu, Hang Shi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 17
Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma
Blažen Marijić, Tamara Braut, Emina Babarović, et al.
Applied immunohistochemistry & molecular morphology (2021) Vol. 29, Iss. 8, pp. 576-584
Closed Access | Times Cited: 13
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
Laura Grumetti, Rita Lombardi, Federica Iannelli, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 695-695
Open Access | Times Cited: 9
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
Kyunghee Burkitt, Vassiliki Saloura
Cancers (2021) Vol. 13, Iss. 20, pp. 5241-5241
Open Access | Times Cited: 12
Recent Advances in the Targeting of Head and Neck Cancer Stem Cells
Kristina Vuković Đerfi, Tea Vasiljević, Tanja Matijević
Applied Sciences (2023) Vol. 13, Iss. 24, pp. 13293-13293
Open Access | Times Cited: 4
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol
Alfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Emerging Therapies in Penile Cancer
Antonio Machado Alencar, Guru Sonpavde
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy
Sabrina Banella, Aishwarya Saraswat, Akanksha Patel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15725-15725
Open Access | Times Cited: 2
Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers
Chunxiu Lin, Peng Liu, Chaowen Shi, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 2, pp. 194-214
Closed Access | Times Cited: 3
Nuclear Epidermal Growth Factor Receptor (Negfr) in Clinical Treatment: A Systematic Review
Junkan Zhu, Zhiyao Wu, Guangyao Shan, et al.
(2024)
Closed Access
Nuclear epidermal growth factor receptor (nEGFR) in clinical treatment
Junkan Zhu, Zhiyao Wu, Guangyao Shan, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e40150-e40150
Closed Access
Exploring Precise Medication Strategies for OSCC Based on Single-Cell Transcriptome Analysis from a Dynamic Perspective
Qingkang Meng, Feng Wu, Guoqi Li, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4801-4801
Open Access | Times Cited: 2
Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo
Hadia H. El Said, Osama A. Badary, Samia A. Shouman, et al.
Canadian Journal of Physiology and Pharmacology (2022) Vol. 100, Iss. 9, pp. 915-925
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top